A Systematic Hierarchical Virtual Screening Model for RhlR Inhibitors Based on PCA, Pharmacophore, Docking, and Molecular Dynamics

• Published in: International journal of molecular sciences Vol. 25; no. 14; p. 8000
• Main Authors: Du, Jiarui, Li, Jiahao, Wen, Juqi, Liu, Jun, Xiao, Haichuan, Zhang, Antian, Yang, Dongdong, Sun, Pinghua, Zhou, Haibo, Xu, Jun
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 22.07.2024
• Subjects: Antibiotics; Bacterial infections; Drug resistance; Hydrocarbons; Hydrogen bonds; Ligands; molecular docking; pharmacophore modeling; Principal components analysis; quorum sensing; RhlR; SAR; Simulation; Systematic review; Variance analysis; virtual screening; Virulence; molecular docking; quorum sensing; virtual screening; SAR; pharmacophore modeling; RhlR; molecular dynamics
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25148000

RhlR plays a key role in the quorum sensing of . The current structure-activity relationship (SAR) studies of RhlR inhibitors mainly focus on elucidating the functional groups. Based on a systematic review of previous research on RhlR inhibitors, this study aims to establish a systematic, hierarchical screening model for RhlR inhibitors. We initially established a database and utilized principal component analysis (PCA) to categorize the inhibitors into two classes. Based on the training set, pharmacophore models were established to elucidate the structural characteristics of ligands. Subsequently, molecular docking, molecular dynamics simulations, and the calculation of binding free energy and strain energy were performed to validate the crucial interactions between ligands and receptors. Then, the screening criteria for RhlR inhibitors were established hierarchically based on ligand structure characteristics, ligand-receptor interaction, and receptor affinity. Test sets were finally employed to validate the hierarchical virtual screening model by comparing it with the current SAR studies of RhlR inhibitors. The hierarchical screening model was confirmed to possess higher accuracy and a true positive rate, which holds promise for subsequent screening and the discovery of active RhlR inhibitors.